Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2600129558Phase 2Not yet recruiting
Phase 2, randomised, open-label trial of epinephrine in intracerebral hemorrhage (ICH) and hydrocephalus (2 arms), sponsored by Changsha Central Hospital. Primary endpoints: Incidence of hemorrhage after drain removal, Incidence of intracranial infection after drain removal and 1 more. Planned start Aug 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2600129558.